Related references
Note: Only part of the references are listed.Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice
Angelica M. Santos et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Fibroblast activation protein α identifies mesenchymal stromal cells from human bone marrow
Sohyun Bae et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy
Karl S. Peggs et al.
IMMUNOLOGICAL REVIEWS (2008)
Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells
Ilaria Marigo et al.
IMMUNOLOGICAL REVIEWS (2008)
IFN-γ- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers
Bin Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness
Gerald Willimsky et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming
Danila Valmori et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Interferons, immunity and cancer immunoediting
Gavin P. Dunn et al.
NATURE REVIEWS IMMUNOLOGY (2006)
A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses:: Spontaneous priming and efficient boosting by vaccination
Daniel E. Speiser et al.
JOURNAL OF IMMUNOLOGY (2006)
Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes
Stefan Bauer et al.
ARTHRITIS RESEARCH & THERAPY (2006)
A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance
M Terabe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma
SA Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2005)
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
A Orimo et al.
CELL (2005)
Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors
P Yu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential
A Peister et al.
BLOOD (2004)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Cutting edge:: CD8+ effector T cells reject tumors by direct antigen recognition but indirect action on host cells
T Schüler et al.
JOURNAL OF IMMUNOLOGY (2003)
Tumor progression despite efficient tumor antigen cross-presentation and effective arming of tumor antigen-specific CTL
DJ Nelson et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
